Investor relations
We are a technology company focusing on specialty pharma products and AI-driven platform for renewable energy
Our proprietary extended-release drug-delivery systems are designed to provide an extended period of post-surgical pain and inflammation relief without the need for repeated dose administration while reducing the potential need for the use of opiates very often administered post surgically.
For further information on our AI-driven technology see https://deepsolar.ai/home/